Cargando…
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?
The aim of this study was to compare effects of an individualized with a standardized risk assessment for adverse drug reactions to improve drug treatment with antithrombotic drugs in older adults. A randomized controlled trial was conducted in general practitioner (GP) offices. Patients aged 60 yea...
Autores principales: | Just, Katja S., Scholl, Catharina, Boehme, Miriam, Kastenmüller, Kathrin, Just, Johannes M., Bleckwenn, Markus, Holdenrieder, Stefan, Meier, Florian, Weckbecker, Klaus, Stingl, Julia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538435/ https://www.ncbi.nlm.nih.gov/pubmed/34681280 http://dx.doi.org/10.3390/ph14101056 |
Ejemplares similares
-
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial
por: Stingl, Julia Carolin, et al.
Publicado: (2016) -
Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment
por: Schneider, Katharina Luise, et al.
Publicado: (2018) -
Risk factors for a positive SARS-CoV-2 PCR in patients with common cold symptoms in a primary care setting – a retrospective analysis based on a joint documentation standard
por: Just, Johannes, et al.
Publicado: (2020) -
Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study
por: Just, Johannes Maximilian, et al.
Publicado: (2018) -
Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
por: Bergs, Ingmar, et al.
Publicado: (2022)